¹Ù·Î°¡±â ¸Þ´º

¹Ù·Î°¡±â ¸Þ´º º»¹®³»¿ë ¹Ù·Î°¡±â ¸ÞÀθ޴º ¹Ù·Î°¡±â

ÁÖ¿ä¾È³»

HOME »çÀÌÆ®¸Ê

FONT SIZE

ÆùƮũ±â Å°¿ò 100% 110% 120% 130% 140% ÆùƮũ±â ÁÙÀÓ
¸Þ´ºº¸±â
 
Á¦¸ñ
4/17 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
ÀÛ¼ºÀÏ
2021-04-16
Á¶È¸¼ö
321


¾È³çÇϼ¼¿ä, ³ª·¡ÀÔ´Ï´Ù. 

À̹øÁÖ Á¦°¡ ¹ßÇ¥ÇÏ°Ô µÉ ³í¹®Àº ¿ÃÇØ 1¿ù plos pathogen¿¡ °ÔÀçµÈ
"Carbomer-based adjuvant elicits CD8 T-cell immunity by inducing a distinct metabolic state in cross-presenting dendritic cells"À̶ó´Â Á¦¸ñÀÇ ³í¹®À¸·Î,

º» ¿¬±¸ÆÀ¿¡¼­ ÀÌÀü¿¡ È¿´ÉÀ» ÀÔÁõÇÏ¿´´ø carbomer-based nano-emulsion adjuvant°¡ ¼öÁö»ó¼¼Æ÷ÀÇ cross-presentation¿¡ ÀÇÇÑ CD8 T ¼¼Æ÷ÀÇ È°¼ºÀ» À¯µµÇÏ´Â ¸ÞÄ¿´ÏÁòÀ» ÅëÇØ ÀÛ¿ëÇÑ´Ù´Â »ç½ÇÀ» metabolism°úµµ ¿¬°áÁö¾î ¼³¸íÇÑ ³í¹®À¸·Î,
¸ÞÄ¿´ÏÁòÀ» ¹àÈ÷±â À§ÇØ »ç¿ëµÈ ½ÇÇè¸ðµ¨ (LM-OVA ¶Ç´Â Vaccinia-OVA °ø°ÝÁ¢Á¾ µî) ¹× ½ÇÇè±â¹ý¿¡ ´ëÇØ Âü°íÇÒ °ÍµéÀÌ ¸¹À» °Í °°¾Æ °øºÎÇغ¸°íÀÚ ¼±Á¤ÇÏ°Ô µÇ¾ú½À´Ï´Ù.

¿­½ÉÈ÷ ÁغñÇÏ¿© Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.


³í¹®¸µÅ©: https://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1009168

÷ºÎÆÄÀÏ:
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
´ÙÀ½±Û
4/24 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä. À̹ø ÁÖ ¹ßÇ¥ÀÚ µµºóÀÔ´Ï´Ù. À̹ø ¼¼¹Ì³ª¿¡ ¹ßÇ¥ÇÒ ³í¹®Àº Cell report¿¡ ÃâÆÇµÈ 'Butyrate protects mice from Clostridium difficile-induced colitis through an HIF-1-dependent mechanism.'ÀÔ´Ï´Ù. Butyrate °¡ colitis ¿ÏÈ­¿¡ È¿°ú¸¦ Áشٴ °ÍÀº Àß ¾Ë·ÁÁø »ç½ÇÀÔ´Ï´Ù. ÀÌ ³í¹®¿¡¼­..
ÀÌÀü±Û
4/17 ¹ßÇ¥³í¹® ÀÔ´Ï´Ù
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä, À̹øÁÖ ¹ßÇ¥ÀÚ ¿µÁø ÀÔ´Ï´Ù. Á¦°¡ ¼±Á¤ÇÑ ³í¹®Àº2019³âµµ JCI¿¡ ÃâÆÇ µÈ "P2Y6 signaling in alveolar macrophages prevents leukotriene-dependent type 2 allergic lung inflammation" ÀÔ´Ï´Ù. ÀÌ ³í¹®¿¡¼­´Â alveolar macrophage¿¡¼­ÀÇUDP/P2Y6 receptorÀÇ Á߿伺À» È®ÀÎÇÏ¿´À¸¸ç ÀÌ´Â IL-..